Clinical trial · Observational
Malignant Pediatric Pelvic Tumors: A Retrospective Study
Malignant Pediatric Pelvi-abdominal Tumors: A Retrospective Study
NCT02557256CI-TRIAL-00068202unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of the study is to retrospectively review data about malignancies that arise primarily in the pelvis and/or in the pelvic organs, in pediatric cancer patients \& categorize the spectrum of these malignancies according to experience at South Egypt Cancer Institute which is the largest referral site in Upper Egypt.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Abdominal Neoplasms | — | UNRESOLVED | — |
| Pelvic Neoplasms | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (2)
- measure
- Overall survival (OS)
- timeFrame
- Participants will be retrospectively followed forward in time from the date of initiation of treatment till the primary completion date of the study, an expected average of 5 years
- description
- Time from the date of initiation of treatment until death from any cause.
- measure
- Event Free Survival (EFS)
- timeFrame
- Participants will be retrospectively followed forward in time from the date of initiation of treatment till the primary completion date of the study, an expected average of 5 years
- description
- Time from the date of initiation of treatment until disease progression, or death for any reason.
Eligibility
Eligibility (as posted)
- Sex
- All
- Maximum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients whose age less than 19 years. * Patients diagnosed with a primary malignant tumor in the pelvis and/or arising from the pelvic organs. Exclusion Criteria: * Patients whose age more than 18 years. * Patients diagnosed with a malignant disease primarily arising from the bone marrow.
References
Publications (2)
- BACKGROUNDGroff DB. Pelvic neoplasms in children. J Surg Oncol. 2001 May;77(1):65-71. doi: 10.1002/jso.1068. PMID 11344486
- BACKGROUNDSkandalakis, J. E. and S. W. Gray (1994). Embryology for surgeons: the embryological basis for the treatment of congenital anomalies, Williams & Wilkins.